Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic disease
LONDON — American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic […]
Novavax Inc's COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a […] Hackensack Meridian Health CEO on COVID-19 vaccination process Bob Garrett, Hackensack Meridian Health CEO, speaks on vaccination progress in New […]Novavax
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
Novavax COVID-19 vaccine could see approval by May, CEO says